Prescription drug · ANDA
Carbidopa-levodopa (Carbidopa and levodopa) NDC 68002-100
Carbidopa 10 mg/1; Levodopa 100 mg/1 · Tablet · Oral · American Health Packaging
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68002-100-04 | 6800201000468002010004 | 30 BLISTER PACK in 1 CARTON (68002-100-04) / 1 TABLET in 1 BLISTER PACK (68002-100-02)Marketed from Jul 28, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbidopa-levodopa
- Generic name (nonproprietary)
- carbidopa and levodopa
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- American Health PackagingNDC labeler code 68002
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216505
- Marketing start
- Listing expires
- Other FDA classes
- Aromatic (Chemical structure)
- Identifiers
- Product ID 68002-100_3a9d54e8-0ed9-4e71-e063-6394a90ac4ffSPL ID 3a9d54e8-0ed9-4e71-e063-6394a90ac4ffSPL set ID dd2215a9-ee0f-443a-a2e3-3d0578c8cd8fRxCUI 197443UNII MNX7R8C5VO, 46627O600J
- Pharmacologic class
- Aromatic Amino Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468002010004followed by a unit qualifier and the quantityPackage 68002-0100-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Carbidopa and levodopa tablets are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa. Carbidopa …
Excerpt only. Read the full label for complete information.
About NDC 68002-100
- What is NDC 68002-100?
- 68002-100 is the product NDC for Carbidopa-levodopa, Carbidopa 10 mg/1; Levodopa 100 mg/1 tablet, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Carbidopa-levodopa (Carbidopa and levodopa).
- What is the active ingredient?
- Carbidopa, Levodopa.
- Who is the labeler?
- American Health Packaging, NDC labeler code 68002. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Carbidopa-levodopa?
- 8 other product NDCs are listed under this name. See all Carbidopa-levodopa NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Carbidopa-levodopa products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Coupler LLC | 67046-1507 | 67046-1507-03 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | TruPharma, LLC | 52817-390 | 52817-0390-1052817-0390-50 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | TruPharma, LLC | 52817-391 | 52817-0391-0052817-0391-1052817-0391-50 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | TruPharma, LLC | 52817-392 | 52817-0392-0052817-0392-1052817-0392-50 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2588 | 71335-2588-0171335-2588-02 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-106 | 72888-0106-0072888-0106-0172888-0106-05+1 more |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-107 | 72888-0107-0072888-0107-0172888-0107-05+1 more |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-108 | 72888-0108-0072888-0108-0172888-0108-05+1 more |
Other NDCs under ANDA 216505
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | TruPharma, LLC | 52817-390 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | TruPharma, LLC | 52817-391 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | TruPharma, LLC | 52817-392 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Coupler LLC | 67046-1507 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2588 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 10 mg/1; Levodopa 100 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-106 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 100 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-107 |
| Carbidopa-levodopacarbidopa and levodopa | Carbidopa 25 mg/1; Levodopa 250 mg/1 | TabletOral | Advagen Pharma Ltd., | 72888-108 |